Industries
Drugs / Biologics
Medical & Surgical
Food
SOX Compliance
IT Control and PCI
Customer Support
Call: 800-447-9407
Fax: 302-288-6884
support@globalcompliancepanel.com
News
...more news
Packs
Featured Speakers
John Bauer
President, Consultjb

John E Lincoln
Consultant, Medical device and Regulatory affairs,

Janet Gough
Director, GXP Documentation
Webinar Search Results
Search Filter Used:
Topic: Not Specified Category: All Speaker: Charles H Pierce Month: Any
Your search returned 5 results

How the Investigator's responsibilities and Legal commitment's in drug and device clinical research affects Study Conduct – The FDA point of view
When the PI signs the FDA form 1572 (for IND studies) or the "Statement of the Investigator (for IDE studies), she / he is signing a legally binding document committing themselves to follow all of the appropriate regulations.
Recorded View Anytime
$295.00

How does compliance with 21 CFR Part 11 help ensure data integrity and subject safety in clinical research
Electronic medical records and electronic handling of study data is increasingly common.
Recorded View Anytime
$295.00

The Secret of Study Conduct Documentation to ensure a successful Audit: What the FDA Inspectors look for
All Clinical Research protocols have the procedures and processes needed to collect the data as it happens.
Recorded View Anytime
$295.00

What is the role of Data and Safety Monitoring in Clinical Research Involving Human Subjects - When and How?
All Clinical Research protocols have a prominent safety monitoring plan as part of the overall research plan / protocol.
Recorded View Anytime
$295.00

Why is Drug Induced Liver Injury an Important Mirror of Drug Safety
The recent media publicity of the FDA warnings about the OTC drug acetaminophen, which is the most common drug cause for liver transplants, has brought into focus the effects of drugs on the liver.
Recorded View Anytime
$295.00

<<